Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty-two-week, randomized, controlled study-Reference-Cited by-同舟云学术

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty-two-week, randomized, controlled study

Published:2005 Issue:4 Volume:52 Page:1205-1215
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

van der Heijde D�sir�e,Baraf Herbert S. B.,Ramos-Remus Cesar,Calin Andrei,Weaver Arthur L.,Schiff Michael,James Margaret,Markind Jan E.,Reicin Alise S.,Melian Agustin,Dougados Maxime

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference35 articles.

1. MANAGEMENT OF REFRACTORY ANKYLOSING SPONDYLITIS AND RELATED SPONDYLOARTHROPATHIES

2. Biologic therapies in the spondyloarthritis: new opportunities, new challenges

3. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

4. Anti-tumour necrosis factor therapy for ankylosing spondylitis: international experience

5. Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of naproxen in patients with sciatica: multicentre, randomized, double-blind, placebo-controlled trial;Pain;2024-06-04

2. Dyslipidemia in rheumatoid arthritis: the possible mechanisms;Frontiers in Immunology;2023-10-25

3. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis;Nature Reviews Rheumatology;2023-10-06

4. Korean treatment recommendations for patients with axial spondyloarthritis;The Korean Journal of Internal Medicine;2023-09-01

5. A Comparative Study on Cyclodextrin Derivatives in Improving Oral Bioavailability of Etoricoxib as a Model Drug: Formulation and Evaluation of Solid Dispersion-Based Fast-Dissolving Tablets;Biomedicines;2023-09-01